ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4,501 | 68.27399 | 0 |
male
| 0 | 15 | 977 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 3 |
$11-$25k
| 0 | 51,694 | 31,447.4531 | 29,663 | 26.666656 |
white
| 18.597656 | 35 | 0.862915 | 0.814941 | 1 | 0 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 15 | 75 | null | 100 | 21 | 36.19531 | null | null | 0.5 | 1.299805 | 141 | null | 91 | 9 | 4,575 | null | 0 |
no(M2 and SIP pres)
| 0 |
4,502 | 68.89294 | 1 |
male
| 1 | 22 | 22 |
COPD
|
COPD/CHF/Cirrhosis
| 3 | 4 |
under $11k
| 0 | 43,100 | 27,005.6719 | 26,722 | 17.666656 |
black
| 23.199219 | 22 | 0.805908 | 0.68689 | 1 | 0 | 0 |
no
| 0.6 | 0.5 |
dnr after sadm
| 18 | 57 | 11.398438 | 150 | 10 | 39.89844 | 102 | null | 2.099609 | 0.799927 | 136 | 7.349609 | 101 | 18 | 2,080 | null | 1 |
<2 mo. follow-up
| 1 |
4,503 | 66.92694 | 1 |
female
| 0 | 6 | 104 |
Lung Cancer
|
Cancer
| 2 | 14 | null | 0 | 8,787 | 4,992.8555 | 3,342 | 11 |
white
| 18 | 12 | 0.68396 | 0.389954 | 1 | 0 | 0 |
metastatic
| 0.6 | 0.2 |
no dnr
| 6 | 69 | 1.099854 | 106 | 26 | 35.89844 | 472 | 2.5 | 1.5 | 1.199951 | 127 | 7.399414 | 196 | 10 | 1,680 | 3 | 2 | null | 2 |
4,504 | 79.23297 | 1 |
female
| 0 | 14 | 865 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 7 |
under $11k
| 0 | 150,446 | 95,675.0625 | 81,663 | 18 |
white
| 26.199219 | 22 | 0.562988 | 0.366943 | 35 | 0 | 0 |
no
| 0.5 | 0.4 |
no dnr
| 14 | 103 | 14.699219 | 128 | 42 | 36.69531 | 364 | 1.899902 | 6.399414 | 2.199707 | 147 | 7.389648 | 113 | 43 | 1,670 | null | 0 |
SIP>=30
| 0 |
4,505 | 44.82999 | 1 |
female
| 1 | 4 | 4 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3 | 14 |
under $11k
| 100 | 4,454 | null | null | 12 |
white
| 46.296875 | 96 | 0.004999 | 0 | 1 | 0 | 0 |
no
| null | null |
dnr after sadm
| 2 | 103 | 15 | 114 | 24 | 33.79688 | 256.5 | 2.099609 | 9.798828 | 1 | 141 | 7.40918 | 113 | 14 | 1,575 | null | null |
<2 mo. follow-up
| 3.859863 |
4,506 | 66.71295 | 1 |
male
| 1 | 6 | 6 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 14 |
under $11k
| 0 | 130,396 | 84,253.5625 | 71,807 | 45 |
white
| 38 | 69 | 0.375977 | 0.257996 | 23 | 0 | 0 |
no
| 0.2 | 0.1 |
dnr after sadm
| 2 | 100 | 14.699219 | 118 | 24 | 36.69531 | 276.625 | null | null | 1.099854 | 135 | 7.469727 | 107 | 18 | 1,445 | null | 0 |
<2 mo. follow-up
| 0 |
4,507 | 70.92694 | 1 |
female
| 1 | 9 | 9 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 16 |
$25-$50k
| 0 | 113,333 | 69,972.8125 | 73,117 | 54 |
white
| 46 | 86 | 0.039993 | 0.011999 | 32 | 0 | 0 |
yes
| 0.3 | 0.3 |
no dnr
| 9 | 74 | 4.099609 | 74 | 10 | 36.59375 | 290.4375 | null | null | 0.899902 | 135 | 7.40918 | 210 | 22 | 2,090 | null | 0 |
<2 mo. follow-up
| 0 |
4,508 | 64.07397 | 1 |
male
| 1 | 15 | 15 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null | null | 9 | 78,530 | 48,207.4375 | 43,088 | 37.333313 |
black
| 24.199219 | 58 | 0.756958 | 0.679932 | 3 | 1 | 0 |
no
| null | null |
dnr after sadm
| 15 | 77 | 16.097656 | 100 | 30 | 35.09375 | 90 | null | null | 1.5 | 146 | 7.229492 | 430 | 27 | null | null | null |
<2 mo. follow-up
| 2.287598 |
4,509 | 63.948 | 0 |
male
| 0 | 12 | 973 |
CHF
|
COPD/CHF/Cirrhosis
| 1 | null |
$11-$25k
| 0 | 22,745 | 13,961.0625 | 13,437 | 28.5 |
black
| 26.898438 | 36 | 0.774902 | 0.641968 | 1 | 0 | 0 |
no
| 0.6 | 0.6 |
no dnr
| 12 | 66 | 32.695313 | 64 | 29 | 35.79688 | 134 | 2 | null | 1.599854 | 132 | 7.399414 | 110 | 21 | 380 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,510 | 66.47498 | 0 |
female
| 0 | 7 | 972 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 13 |
$11-$25k
| 0 | 5,886 | 4,096.3672 | 3,634 | 10.5 |
black
| 20.898438 | 27 | 0.846924 | 0.748901 | 1 | 1 | 0 |
no
| null | null |
no dnr
| 7 | 65 | 16.699219 | 104 | 40 | 36.5 | 200 | 2.399902 | 22.5 | 1.199951 | 139 | 7.459961 | 199 | 38 | 4,450 | 1 | null |
no(M2 and SIP pres)
| 1.166748 |
4,511 | 54.92398 | 1 |
male
| 1 | 6 | 6 |
Coma
|
Coma
| 2 | null | null | 100 | 25,869 | 19,248.6094 | 14,186 | 16 | null | 20.699219 | 38 | 0.32196 | 0.250977 | 6 | 0 | 0 |
no
| null | null |
dnr after sadm
| 1 | 67 | 4.5 | 100 | 22 | 36 | null | null | 0.399963 | 1 | 139 | null | 98 | 19 | 1,500 | null | null |
<2 mo. follow-up
| 2.609375 |
4,512 | 57.91397 | 1 |
female
| 0 | 5 | 17 |
Lung Cancer
|
Cancer
| 1 | 12 |
>$50k
| 0 | 7,104 | null | null | 8 |
white
| 22 | 25 | 0.616943 | 0.302979 | 1 | 0 | 0 |
metastatic
| 0.5 | 0.2 |
no dnr
| 5 | 71 | 13.5 | 73 | 25 | 36.69531 | 155 | null | 0.699951 | 7.099609 | 148 | 7.40918 | 200 | 57 | 1,960 | 5 | 4 |
<2 mo. follow-up
| 4 |
4,513 | 30.84698 | 1 |
female
| 0 | 66 | 896 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 11 | null | 100 | 95,845 | 64,135.25 | 69,807 | 16.75 |
black
| 22.097656 | 20 | 0.671997 | 0.575928 | 1 | 0 | 0 |
no
| 0.9 | 0.95 |
no dnr
| 66 | 65 | 14.798828 | 50 | 12 | 36.89844 | 152.5 | 2.099609 | 0.799927 | 0.799927 | 136 | 7.459961 | 108 | 18 | 780 | null | null | null | 3.235352 |
4,514 | 36.92499 | 1 |
female
| 1 | 28 | 28 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 14 |
$11-$25k
| 0 | 151,066 | 95,726.5 | 83,119 | 33.25 |
white
| 30 | 45 | 0.815918 | 0.754883 | 1 | 0 | 0 |
no
| 0.6 | 0.6 |
dnr after sadm
| 14 | 129 | 11.398438 | 56 | 45 | 39.39844 | 284 | null | null | 0.899902 | 144 | 7.459961 | 243 | 12 | 2,110 | null | 0 |
<2 mo. follow-up
| 0 |
4,515 | 44.32898 | 1 |
male
| 0 | 5 | 864 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 8 |
$25-$50k
| 0 | null | null | null | 11 |
white
| 21.597656 | 22 | 0.897949 | 0.829956 | 1 | 1 | 0 |
no
| 0.8 | 0.7 | null | null | 83 | null | 70 | 12 | 36.29688 | null | null | null | null | 140 | null | 282 | null | 3,800 | 0 | null |
no(M2 and SIP pres)
| 0.494751 |
4,516 | 47.37299 | 1 |
female
| 1 | 24 | 24 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3 | 16 | null | 0 | 101,234 | 67,325.0625 | 57,193 | 40.333313 |
black
| 55.59375 | 82 | 0.054993 | 0.006 | 1 | 0 | 0 |
no
| 0.5 | 0.5 |
dnr after sadm
| 20 | 97 | 28.796875 | 106 | 46 | 38 | 151 | 2.399902 | 1.5 | 1.299805 | 136 | 7.449219 | 87 | 17 | 2,950 | null | 1 |
<2 mo. follow-up
| 1 |
4,517 | 67.53699 | 1 |
male
| 0 | 8 | 54 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | null |
under $11k
| 0 | 16,884 | 10,548.1094 | 9,162 | 17 |
black
| 17.597656 | 20 | 0.868896 | 0.782959 | 2 | 0 | 0 |
no
| 0.5 | 0.5 |
no dnr
| 8 | 100 | 6 | 84 | 24 | 36.29688 | 176.1875 | null | 0.699951 | 0.699951 | 140 | 7.339844 | 115 | 18 | 3,025 | null | 4 |
<2 mo. follow-up
| 4 |
4,518 | 59.76199 | 1 |
male
| 0 | 6 | 136 |
Lung Cancer
|
Cancer
| 1 | 6 |
$11-$25k
| 0 | 13,286 | 6,966.7109 | 5,383 | 15 |
black
| 15.298828 | 22 | 0.751953 | 0.493958 | 1 | 0 | 0 |
metastatic
| 0.5 | 0.25 |
no dnr
| 6 | 77 | 7.099609 | 80 | 20 | 36.09375 | null | 3.699707 | 0.5 | 0.799927 | 139 | null | 157 | 12 | 2,650 | 2 | 2 |
SIP>=30
| 2 |
4,519 | 67.55096 | 1 |
male
| 1 | 3 | 3 |
MOSF w/Malig
|
ARF/MOSF
| 1 | null | null | 37 | 49,159 | 30,353.2031 | 25,562 | 31 | null | 59.195313 | 98 | 0 | 0 | 12 | 0 | 0 |
yes
| null | null |
no dnr
| 3 | 53 | 8.898438 | 110 | 23 | 36 | 197.9375 | null | null | 3.099609 | 129 | 7.339844 | 108 | 103 | 380 | null | null |
<2 mo. follow-up
| 1.974365 |
4,520 | 77.659 | 1 |
male
| 0 | 61 | 162 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
under $11k
| 9 | 219,246 | 146,584.75 | 144,700 | 40.75 |
white
| 28 | 44 | 0.612915 | 0.506958 | 3 | 0 | 0 |
no
| null | null |
no dnr
| 61 | 115 | 9.5 | 70 | 23 | 36.09375 | null | 3.699707 | 0.799927 | 1.199951 | 142 | null | 112 | 7 | 4,600 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
4,521 | 72.42395 | 1 |
male
| 0 | 21 | 656 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null | null | 0 | 30,845 | 20,463.3125 | 20,964 | 19.666656 |
white
| 24 | 42 | 0.781982 | 0.710938 | 1 | 0 | 0 |
no
| 0.85 | 0.75 |
no dnr
| 21 | 65 | 20.398438 | 136 | 12 | 39.59375 | 208 | 1.899902 | 0.399963 | 0.899902 | 135 | 7.40918 | 72 | 7 | 2,010 | null | null | null | 2.82666 |
4,522 | 37.71698 | 1 |
female
| 1 | 27 | 27 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
under $11k
| 0 | 123,504 | 83,198.125 | 66,476 | 42.25 |
white
| 35 | 64 | 0.733887 | 0.651978 | 1 | 0 | 0 |
no
| 0.25 | 0.25 |
dnr after sadm
| 10 | 55 | 12.199219 | 74 | 38 | 35.5 | 290 | null | null | 5.799805 | 139 | 7.40918 | 218 | 120 | 110 | null | 6 |
<2 mo. follow-up
| 6 |
4,523 | 73.22699 | 1 |
female
| 0 | 113 | 173 |
Coma
|
Coma
| 0 | 2 | null | 55 | 173,742 | 123,581.25 | 124,106 | 28 |
white
| 22.5 | 18 | 0.396973 | 0.322998 | 1 | 0 | 0 |
no
| null | null |
dnr after sadm
| 38 | 121 | 8.298828 | 124 | 32 | 36.09375 | 162.5 | null | 1.5 | 0.699951 | 145 | 7.519531 | 179 | 35 | 1,755 | null | 1 |
adl>=4 (>=5 if sur)
| 1 |
4,524 | 56.05698 | 1 |
female
| 1 | 3 | 3 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4 | 15 |
$11-$25k
| 61 | 44,639 | 29,698.5469 | 29,694 | 12 |
black
| 77.890625 | 94 | 0 | 0 | 22 | 1 | 0 |
no
| 0.1 | 0.1 |
dnr after sadm
| 2 | 0 | 15.798828 | 0 | 0 | 35.5 | 232.5 | null | null | 2 | 153 | 7.449219 | 378 | 26 | 5,635 | null | 3 |
<2 mo. follow-up
| 3 |
4,525 | 63.84698 | 1 |
male
| 1 | 3 | 3 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 20 |
>$50k
| 100 | 39,993 | 25,133.3281 | 23,895 | 3 |
white
| 31.796875 | 48 | 0.132996 | 0.060997 | 5 | 1 | 0 |
no
| null | null |
dnr after sadm
| 2 | 73 | 14.699219 | 130 | 32 | 36.19531 | 300 | 2.599609 | 1.099854 | 2 | 141 | 7.439453 | 150 | 28 | 443 | null | null |
<2 mo. follow-up
| 3.532715 |
4,526 | 68.73895 | 0 |
male
| 0 | 12 | 965 |
COPD
|
COPD/CHF/Cirrhosis
| 1 | null | null | 0 | 11,075 | 7,144.2578 | 8,268 | 11 |
other
| 17.898438 | 15 | 0.869995 | 0.783936 | 1 | 0 | 0 |
no
| 0.9 | 0.8 |
dnr after sadm
| 10 | 156 | 14.599609 | 124 | 32 | 38.19531 | 208.5625 | null | null | 0.899902 | 146 | 7.439453 | 297 | 47 | 2,010 | null | null | null | 2.753418 |
4,527 | 67.35095 | 1 |
female
| 0 | 7 | 69 |
Lung Cancer
|
Cancer
| 1 | 11 |
$25-$50k
| 0 | 12,901 | 7,968.5469 | 7,785 | 3.5 |
white
| 20.597656 | 19 | 0.623901 | 0.310974 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.75 |
no dnr
| 7 | 69 | 14.398438 | 114 | 36 | 36.29688 | 87.75 | null | null | 1 | 138 | 7.429688 | 160 | 23 | 3,050 | 4 | 3 | null | 3 |
4,528 | 43.047 | 1 |
female
| 1 | 5 | 5 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 16 |
$25-$50k
| 0 | 20,626 | 15,471.5938 | 11,961 | 48 |
white
| 29.597656 | 28 | 0.527954 | 0.411987 | 1 | 0 | 0 |
metastatic
| 0.2 | 0.1 |
dnr after sadm
| 3 | 59 | 17 | 116 | 16 | 38.79688 | 145.4375 | 2.899902 | 0.699951 | 1.099854 | 137 | 7.479492 | 128 | 19 | 1,250 | null | null |
<2 mo. follow-up
| 2.361328 |
4,529 | 50.71597 | 1 |
male
| 0 | 5 | 297 |
Colon Cancer
|
Cancer
| 1 | 14 | null | 0 | 5,168 | 3,181.8672 | 3,450 | 13 |
black
| 7.799805 | 29 | 0.921997 | 0.816895 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 5 | 69 | 16.097656 | 70 | 14 | 38.19531 | 212.5 | 1.699951 | 1.699951 | 1.699951 | 142 | 7.419922 | 199 | 53 | 3,865 | 1 | 1 |
no(M2 and SIP pres)
| 1 |
4,530 | 58.448 | 1 |
female
| 1 | 9 | 9 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 16 |
>$50k
| 0 | 53,336 | 33,709.875 | 27,935 | 43.5 |
white
| 33.296875 | 47 | 0.449951 | 0.329956 | 2 | 0 | 0 |
yes
| 0.3 | 0.2 |
dnr after sadm
| 9 | 82 | 10 | 72 | 20 | 37 | null | 4.199219 | 0.399963 | 0.899902 | 141 | null | 96 | 12 | null | 4 | 5 |
<2 mo. follow-up
| 5 |
4,531 | 36.62097 | 1 |
female
| 1 | 8 | 8 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
$25-$50k
| 37 | 40,649 | 26,247.6094 | 23,098 | 42 |
white
| 42.5 | 81 | 0.390991 | 0.271973 | 1 | 0 | 0 |
no
| 0.5 | 0.5 |
dnr after sadm
| 7 | 69 | 19.898438 | 66 | 20 | 37.39844 | 148.96875 | 2.699707 | null | 3.899902 | 130 | 7.5 | 237 | 62 | 2,970 | null | 0 |
<2 mo. follow-up
| 0 |
4,532 | 41.92697 | 1 |
female
| 1 | 8 | 8 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
$25-$50k
| 44 | 206,256 | 138,603.875 | 142,798 | 47.5 |
white
| 22.597656 | 41 | 0.721924 | 0.635986 | 22 | 0 | 0 |
no
| 0.75 | 0.7 |
dnr after sadm
| 7 | 113 | 7.699219 | 74 | 22 | 33.79688 | 230.59375 | 1.899902 | 0.699951 | 1.099854 | 135 | 7.329102 | 290 | 15 | 2,240 | null | 0 |
<2 mo. follow-up
| 0 |
4,533 | 24.101 | 0 |
female
| 0 | 10 | 958 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 | null | 0 | 10,079 | 6,416.2148 | 6,694 | 12.5 |
white
| 20.699219 | 36 | 0.927979 | 0.901978 | 1 | 0 | 0 |
no
| 1 | 0.75 |
no dnr
| 10 | 49 | 13 | 60 | 6 | 36.79688 | 265 | 2.399902 | 1.599854 | 2 | 150 | 7.369141 | 100 | 66 | 1,490 | 2 | 3 |
adl>=4 (>=5 if sur)
| 3 |
4,534 | 76.97198 | 1 |
male
| 0 | 8 | 608 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | null |
$11-$25k
| 0 | 17,070 | 10,639.7812 | 10,958 | 11.5 |
white
| 20.796875 | 34 | 0.813965 | 0.697998 | 1 | 1 | 0 |
no
| 0.8 | 0.75 |
no dnr
| 8 | 73 | 8.5 | 46 | 16 | 35.79688 | 152.375 | null | 1.099854 | 1.799805 | 144 | 7.429688 | 88 | 29 | 1,000 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,535 | 68.62994 | 0 |
male
| 0 | 69 | 960 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 37 | 134,910 | null | null | 22.75 |
black
| 18.597656 | 24 | 0.720947 | 0.634888 | 8 | 0 | 0 |
no
| 0.5 | 0.3 |
no dnr
| 69 | 39 | 1 | 144 | 28 | 38.89844 | 160 | 2.299805 | 2.199707 | 5 | 143 | 7.219727 | 70 | 68 | 975 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
4,536 | 50.23099 | 1 |
male
| 0 | 44 | 312 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 12 | null | 0 | 151,085 | 98,833.75 | 96,276 | 27.25 |
white
| 39.695313 | 74 | 0.221985 | 0.123993 | 1 | 0 | 0 |
metastatic
| null | null |
dnr after sadm
| 10 | 52 | 9.398438 | 64 | 16 | 36.5 | null | 3.099609 | 0.599976 | 0.799927 | 138 | null | 294 | 9 | 5,525 | null | 4 |
adl>=4 (>=5 if sur)
| 4 |
4,537 | 52.91199 | 1 |
male
| 1 | 9 | 9 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 | null | 0 | 101,406 | 63,986.6562 | 56,224 | 34 |
white
| 24.699219 | 34 | 0.718994 | 0.632935 | 30 | 0 | 0 |
yes
| 0.5 | 0.2 |
dnr after sadm
| 3 | 151 | 9.798828 | 134 | 30 | 35.29688 | 174 | null | 0.399963 | 4 | 132 | 7.369141 | 129 | 50 | 670 | null | 3 |
<2 mo. follow-up
| 3 |
4,538 | 62.86398 | 0 |
male
| 0 | 5 | 957 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | 16 |
$25-$50k
| 0 | null | null | null | 7 |
white
| 13 | 13 | 0.922974 | 0.869995 | 1 | 1 | 0 |
no
| 0.9 | 0.8 | null | null | 0 | 7.199219 | 0 | 10 | 36.09375 | 115 | 2.399902 | 17.699219 | 1.099854 | 139 | 7.399414 | 51 | 23 | 195 | 1 | 0 |
no(M2 and SIP pres)
| 0 |
4,539 | 38.78198 | 1 |
male
| 0 | 8 | 63 |
CHF
|
COPD/CHF/Cirrhosis
| 1 | 16 |
under $11k
| 0 | 8,195 | 5,477.7969 | 5,594 | 8.5 |
white
| 22.796875 | 17 | 0.899902 | 0.832886 | 1 | 0 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 8 | 153 | 18.898438 | 160 | 40 | 36.19531 | 156 | null | 0.699951 | 0.5 | 131 | 7.429688 | 78 | 6 | 1,945 | 0 | null | null | 0.494751 |
4,540 | 42.83398 | 0 |
female
| 0 | 68 | 956 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 | null | 0 | 293,248 | 206,553.625 | 219,449 | 42 |
black
| 27.398438 | 44 | 0.767944 | 0.69397 | 28 | 0 | 0 |
no
| 0.75 | 0.65 |
no dnr
| 68 | 53 | 17.5 | 120 | 14 | 38.39844 | 147.125 | 2.599609 | 1 | 1 | 135 | 7.489258 | 124 | 16 | 2,320 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
4,541 | 63.44397 | 1 |
female
| 1 | 4 | 4 |
Coma
|
Coma
| 1 | null | null | 100 | 20,151 | 13,220.0391 | 11,825 | 38 |
white
| 30.898438 | 72 | 0.070999 | 0.039993 | 1 | 0 | 0 |
no
| null | null |
dnr after sadm
| 2 | 70 | 5.599609 | 62 | 20 | 36.39844 | null | null | 0.899902 | 0.899902 | 138 | null | 79 | 11 | null | null | null |
<2 mo. follow-up
| 2.631348 |
4,542 | 71.10699 | 1 |
female
| 0 | 14 | 79 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 10 |
under $11k
| 0 | 11,445 | 7,709.0078 | 8,895 | 7.333332 |
white
| 21.097656 | 26 | 0.778931 | 0.647949 | 1 | 0 | 0 |
yes
| 0.6 | 0.5 |
dnr after sadm
| 2 | 55 | 39.59375 | 104 | 10 | 36.59375 | 164 | null | 1.599854 | 1.899902 | 133 | 7.339844 | 253 | 122 | 618 | null | 0 |
no(M2 and SIP pres)
| 0 |
4,543 | 53.73898 | 1 |
female
| 1 | 86 | 86 |
MOSF w/Malig
|
ARF/MOSF
| 2 | 16 |
>$50k
| 0 | 264,539 | 180,809.375 | 156,199 | 36.75 |
white
| 25.296875 | 64 | 0.618896 | 0.514893 | 1 | 0 | 0 |
metastatic
| 0.4 | 0.2 |
dnr after sadm
| 4 | 119 | 9.398438 | 44 | 42 | 39.79688 | 363.3125 | null | null | 1.099854 | 143 | 7.519531 | 133 | 17 | 2,230 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
4,544 | 19.14899 | 0 |
male
| 0 | 16 | 953 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 11 |
$11-$25k
| 0 | 43,894 | 29,063.0938 | 25,630 | 13.333328 |
black
| 26.199219 | 32 | 0.878906 | 0.836914 | 5 | 0 | 0 |
no
| 0.9 | 0.9 |
no dnr
| 16 | 79 | 7.599609 | 92 | 26 | 39 | null | 3 | 0.599976 | 2.099609 | 139 | null | 99 | 21 | 2,425 | 0 | 5 |
no(M2 and SIP pres)
| 5 |
4,545 | 68.31995 | 1 |
male
| 1 | 3 | 3 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 12 |
$11-$25k
| 0 | 56,203 | 35,560.4375 | 29,180 | 34 |
white
| 46.59375 | 102 | 0.166992 | 0.084 | 6 | 0 | 0 |
no
| null | null |
dnr after sadm
| 3 | 99 | 2.5 | 100 | 24 | 36.69531 | null | 3.799805 | 0.599976 | 1.299805 | 138 | null | 339 | 23 | null | null | 6 |
<2 mo. follow-up
| 6 |
4,546 | 72.99097 | 1 |
male
| 1 | 14 | 14 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 | null | 0 | 62,598 | 41,066.875 | 35,585 | 19 |
black
| 30.796875 | 49 | 0.575928 | 0.465942 | 1 | 0 | 0 |
yes
| 0.7 | 0.6 |
dnr after sadm
| 12 | 75 | 5.799805 | 56 | 16 | 36.59375 | null | 4.099609 | 0.399963 | 1.299805 | 138 | null | 249 | 48 | 2,225 | null | 1 |
<2 mo. follow-up
| 1 |
4,547 | 72.90295 | 1 |
male
| 0 | 8 | 36 |
Lung Cancer
|
Cancer
| 2 | 12 | null | 0 | 5,657 | 3,751.4981 | 3,824 | 6.5 |
white
| 38.398438 | 52 | 0.120987 | 0.004999 | 1 | 1 | 0 |
metastatic
| 1 | 0.95 |
no dnr
| 8 | 107 | 14.298828 | 124 | 10 | 35.69531 | 127.5 | 3.299805 | 0.5 | 2.5 | 131 | 7.519531 | 103 | 128 | 3,145 | 7 | 6 |
<2 mo. follow-up
| 6 |
4,548 | 19.96199 | 0 |
female
| 0 | 28 | 951 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
$25-$50k
| 0 | 105,433 | 71,099.1875 | 59,291 | 36.25 |
black
| 31.5 | 53 | 0.848999 | 0.796997 | 1 | 0 | 0 |
no
| 0.75 | 0.7 |
no dnr
| 28 | 75 | 10.898438 | 72 | 36 | 37.89844 | 228 | 3.899902 | null | 1.399902 | 134 | 7.289062 | 105 | 21 | 6,710 | null | 0 |
no(M2 and SIP pres)
| 0 |
4,549 | 63.74298 | 0 |
female
| 0 | 15 | 950 |
CHF
|
COPD/CHF/Cirrhosis
| 1 | 15 |
$25-$50k
| 0 | 50,256 | 30,249.4531 | 25,637 | 18.333328 |
white
| 14.898438 | 27 | 0.908936 | 0.845947 | 1 | 0 | 0 |
no
| 0.9 | 0.75 |
no dnr
| 15 | 119 | 16.597656 | 66 | 34 | 35.29688 | 376 | 3.199707 | 1 | 0.799927 | 139 | 7.449219 | 199 | 27 | 3,485 | 0 | 2 |
no(M2 and SIP pres)
| 2 |
4,550 | 59.48798 | 1 |
male
| 0 | 9 | 149 |
Colon Cancer
|
Cancer
| 1 | 12 |
$11-$25k
| 0 | 11,417 | 7,147.6914 | 7,076 | 8 |
white
| 16.597656 | 20 | 0.832886 | 0.634888 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 9 | 70 | 7.699219 | 64 | 18 | 36.39844 | null | 3.199707 | 0.5 | 1 | 139 | null | 113 | 9 | 4,000 | 0 | 0 |
SIP>=30
| 0 |
4,551 | 31.797 | 0 |
male
| 0 | 51 | 950 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 11 |
$11-$25k
| 0 | 113,949 | 73,953.375 | 72,932 | 31.75 |
white
| 26.796875 | 53 | 0.86792 | 0.821899 | 1 | 1 | 0 |
no
| 0.6 | 0.6 |
dnr after sadm
| 10 | 109 | 3.399902 | 116 | 28 | 36.5 | 320 | 3 | 0.399963 | 0.899902 | 129 | 7.479492 | 76 | 13 | 3,820 | null | 1 |
no(M2 and SIP pres)
| 1 |
4,552 | 65.45898 | 1 |
female
| 0 | 9 | 41 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 6 | null | 0 | 12,912 | 9,768.9141 | 6,986 | 15 |
white
| 20.898438 | 31 | 0.850952 | 0.754883 | 1 | 0 | 0 |
no
| 0.99 | 0.95 |
no dnr
| 9 | 60 | 15.599609 | 140 | 36 | 35 | null | 2.199707 | 18.097656 | 6.299805 | 126 | null | 111 | 51 | 80 | 0 | 2 |
<2 mo. follow-up
| 2 |
4,553 | 74.672 | 1 |
male
| 1 | 3 | 3 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 8 | null | 0 | 48,434 | 28,172.8281 | 31,747 | 44 |
white
| 89.6875 | 96 | 0 | 0 | 16 | 0 | 0 |
yes
| null | null |
dnr after sadm
| 3 | 61 | 21.296875 | 104 | 35 | 38.5 | 225 | 2.299805 | 28.5 | 6.899414 | 131 | 7.349609 | 142 | 110 | 1,320 | null | null |
<2 mo. follow-up
| 1.112793 |
4,554 | 58.40698 | 1 |
male
| 0 | 5 | 11 |
Lung Cancer
|
Cancer
| 1 | 12 |
$25-$50k
| 0 | 7,980 | 4,603.7109 | 3,679 | 6 |
white
| 24.296875 | 21 | 0.555908 | 0.233978 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 5 | 68 | 2 | 106 | 31 | 36 | 172.5 | 2.099609 | 22.097656 | 3.5 | 136 | 7.349609 | 76 | 117 | 130 | null | null |
<2 mo. follow-up
| 2.232422 |
4,555 | 39.34598 | 1 |
male
| 1 | 8 | 8 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 | null | 94 | 37,006 | 24,103.6406 | 18,252 | 32 |
black
| 19.898438 | 33 | 0.662964 | 0.565918 | 3 | 0 | 0 |
no
| 0.02 | 0 |
dnr after sadm
| 4 | 59 | 9.599609 | 60 | 32 | 36.19531 | 301.625 | null | null | 2.5 | 143 | 7.40918 | 235 | 99 | 1,180 | null | 0 |
<2 mo. follow-up
| 0 |
4,556 | 41.90799 | 1 |
female
| 1 | 23 | 23 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 13 |
$11-$25k
| 0 | 113,704 | 73,262.5625 | 57,339 | 28.333328 |
white
| 24 | 37 | 0.619995 | 0.515991 | 4 | 0 | 0 |
metastatic
| 0.2 | 0.1 |
dnr after sadm
| 23 | 127 | 8.898438 | 150 | 10 | 39.59375 | 218 | 2.899902 | 1.799805 | 0.799927 | 132 | 7.399414 | 107 | 8 | 630 | null | 4 |
<2 mo. follow-up
| 4 |
4,557 | 77.26495 | 1 |
male
| 1 | 16 | 16 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 11 | null | 0 | 53,824 | 32,864.5625 | 28,672 | 24.333328 |
white
| 32.59375 | 65 | 0.577881 | 0.467957 | 1 | 1 | 0 |
no
| 0.8 | 0.8 |
dnr after sadm
| 16 | 111 | 6.799805 | 66 | 24 | 36.89844 | null | null | null | 3.699707 | 141 | null | 169 | 26 | 1,500 | null | 3 |
<2 mo. follow-up
| 3 |
4,558 | 65.67798 | 1 |
male
| 0 | 16 | 230 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4 | 2 |
under $11k
| 0 | 30,435 | 20,161.2969 | 19,058 | 16.333328 |
black
| 30.796875 | 59 | 0.618896 | 0.513916 | 1 | 0 | 0 |
yes
| 0.5 | 0.5 |
no dnr
| 16 | 171 | 11 | 116 | 26 | 37.69531 | 393.3125 | null | null | 1.199951 | 145 | 7.599609 | 144 | 25 | 1,565 | 4 | 0 |
no(M2 and SIP pres)
| 0 |
4,559 | 49.29199 | 1 |
female
| 0 | 14 | 221 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 9 |
$25-$50k
| 0 | 23,026 | 14,854.1719 | 13,023 | 16.333328 |
white
| 26.699219 | 28 | 0.726929 | 0.642944 | 1 | 0 | 0 |
metastatic
| 0.3 | 0.2 |
no dnr
| 14 | 75 | 10.798828 | 110 | 24 | 36.5 | 309.5 | 3.399902 | 0.5 | 0.699951 | 134 | 7.459961 | 101 | 9 | 1,700 | null | 1 | null | 1 |
4,560 | 77.17999 | 1 |
female
| 1 | 20 | 20 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4 | 8 |
under $11k
| 9 | 32,283 | 20,509.1406 | 21,574 | 15.333328 |
black
| 32.398438 | 53 | 0.485962 | 0.367981 | 4 | 1 | 0 |
no
| 0.1 | 0.1 |
dnr after sadm
| 6 | 67 | 19.898438 | 124 | 14 | 38.89844 | 250 | null | 0.5 | 0.699951 | 147 | 7.40918 | 186 | 3 | 4,880 | null | 4 |
<2 mo. follow-up
| 4 |
4,561 | 74.52399 | 0 |
male
| 0 | 17 | 944 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
$11-$25k
| 0 | 74,630 | 46,074.6562 | 46,423 | 19.666656 |
white
| 29.898438 | 55 | 0.564941 | 0.452942 | 14 | 1 | 0 |
no
| null | null |
no dnr
| 17 | 129 | 19.199219 | 136 | 12 | 39.09375 | 124 | 1.799805 | 0.899902 | 0.399963 | 140 | 7.389648 | 118 | 11 | 1,485 | null | 0 |
no(M2 and SIP pres)
| 0 |
4,562 | 76.70898 | 1 |
male
| 1 | 46 | 46 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 7 |
under $11k
| 0 | 167,401 | 99,435.5 | 108,604 | 33.75 |
white
| 25 | 40 | 0.746948 | 0.667969 | 1 | 0 | 0 |
no
| null | null |
dnr after sadm
| 41 | 69 | 8.199219 | 100 | 12 | 36.19531 | 271.375 | null | null | 0.599976 | 134 | 7.449219 | 146 | 12 | 2,600 | null | 4 |
<2 mo. follow-up
| 4 |
4,563 | 66.59497 | 1 |
female
| 1 | 4 | 4 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2 | 14 | null | 26 | 5,718 | 3,435.2969 | 3,310 | 16 |
hispanic
| 31.796875 | 66 | 0.338989 | 0.151978 | 1 | 0 | 0 |
no
| 0 | 0 |
dnr after sadm
| 2 | 41 | 21.199219 | 134 | 48 | 35.59375 | 72 | 2.299805 | 10.599609 | 0.699951 | 141 | 7.479492 | 85 | 16 | 1,430 | null | 7 |
<2 mo. follow-up
| 7 |
4,564 | 67.02795 | 1 |
male
| 0 | 6 | 101 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 12 |
$11-$25k
| 0 | 13,864 | 8,040.1992 | 8,058 | 22 |
white
| 17.097656 | 35 | 0.883911 | 0.805908 | 1 | 1 | 0 |
no
| null | null |
no dnr
| 6 | 68 | 10 | 66 | 22 | 36.59375 | 364 | null | null | 0.799927 | 132 | 7.5 | 87 | 7 | 1,190 | 0 | 1 |
no(M2 and SIP pres)
| 1 |
4,565 | 47.26099 | 1 |
male
| 0 | 7 | 266 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 6 |
$11-$25k
| 0 | 5,337 | 3,614.2812 | 3,325 | 10 |
black
| 21.796875 | 26 | 0.889893 | 0.815918 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 7 | 63 | 7.599609 | 100 | 20 | 37.09375 | null | null | 0.399963 | 1.199951 | 142 | null | 51 | 6 | 3,200 | 1 | 2 |
no(M2 and SIP pres)
| 2 |
4,566 | 49.69199 | 1 |
male
| 1 | 6 | 6 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1 | 12 |
$11-$25k
| 41 | 30,257 | 22,688.4844 | 17,038 | 32 |
white
| 37.296875 | 68 | 0.255981 | 0.092987 | 2 | 0 | 0 |
no
| 0.3 | 0.3 |
dnr after sadm
| 4 | 30 | 1.199951 | 0 | 10 | 37.19531 | 246 | null | 2.099609 | 4 | 137 | 7.289062 | 154 | 99 | 120 | null | 0 |
<2 mo. follow-up
| 0 |
4,567 | 49.5 | 1 |
female
| 1 | 15 | 15 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
>$50k
| 0 | 92,135 | 57,447.5938 | 53,565 | 53.333313 |
white
| 42.898438 | 69 | 0.397949 | 0.278992 | 6 | 1 | 0 |
no
| 0.6 | 0.6 |
dnr after sadm
| 15 | 67 | 4.5 | 130 | 28 | 36.79688 | 185.6875 | 3.299805 | null | 0.699951 | 143 | 7.459961 | 285 | 25 | 4,300 | null | 3 |
<2 mo. follow-up
| 3 |
4,568 | 72.87598 | 1 |
male
| 0 | 7 | 193 |
Lung Cancer
|
Cancer
| 3 | 16 | null | 0 | 6,623 | 4,288.4531 | 4,394 | 8.5 |
white
| 17.097656 | 9 | 0.68689 | 0.393982 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.6 |
no dnr
| 7 | 135 | 16.398438 | 116 | 28 | 35.89844 | 370.3125 | null | 0.599976 | 1.299805 | 137 | 7.459961 | 262 | 29 | 1,458 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,569 | 21.59299 | 1 |
male
| 0 | 20 | 342 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | null | null | 44 | 35,222 | 22,459.4531 | 20,857 | 21.333328 |
white
| 15.599609 | 4 | 0.915894 | 0.884888 | 1 | 0 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 20 | 63 | 30.597656 | 144 | 25 | 38.89844 | 74 | 2.399902 | 0.899902 | 0.799927 | 130 | 7.319336 | 111 | 20 | 2,390 | null | null |
Coma or Intub
| 1.914551 |
4,570 | 65.27295 | 1 |
male
| 0 | 11 | 843 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 10 |
$11-$25k
| 0 | 31,903 | 19,699.6562 | 20,405 | 22 |
white
| 36.796875 | 45 | 0.460999 | 0.34198 | 7 | 0 | 0 |
no
| 0.5 | 0.4 |
no dnr
| 11 | 118 | 17.199219 | 114 | 34 | 38.69531 | 413.3125 | 3.299805 | 1 | 0.599976 | 136 | 7.479492 | 124 | 6 | 3,670 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,571 | 40.30099 | 1 |
female
| 0 | 7 | 291 |
Lung Cancer
|
Cancer
| 1 | 16 |
$25-$50k
| 0 | 5,085 | 3,449.3496 | 4,165 | 9.5 |
white
| 33.398438 | 40 | 0.356995 | 0.077988 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.5 |
no dnr
| 7 | 0 | 23.097656 | 0 | 0 | 39.79688 | 368 | null | 3.199707 | 6.099609 | 135 | 7.419922 | 187 | 67 | 0 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,572 | 51.09097 | 0 |
male
| 0 | 60 | 940 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 14 |
under $11k
| 0 | 167,620 | 98,773.0625 | 104,292 | 28.25 |
white
| 33.5 | 71 | 0.618896 | 0.513916 | 12 | 0 | 0 |
no
| null | null |
no dnr
| 60 | 58 | 22.097656 | 95 | 9 | 35.89844 | 163.25 | 2.199707 | 1.799805 | 1.399902 | 128 | 7.399414 | 332 | 33 | 8,340 | 1 | 2 |
SIP>=30
| 2 |
4,573 | 31.59499 | 0 |
male
| 0 | 10 | 940 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 11 | null | 0 | 27,143 | 16,342.8125 | 15,221 | 16.5 |
black
| 27.597656 | 53 | 0.849976 | 0.79895 | 2 | 0 | 0 |
no
| null | null |
no dnr
| 10 | 106 | 12.5 | 94 | 21 | 36 | 388.875 | null | 0.599976 | 0.899902 | 137 | 7.30957 | 126 | 22 | null | 1 | 0 |
no(M2 and SIP pres)
| 0 |
4,574 | 39.797 | 0 |
male
| 0 | 5 | 940 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3 | 14 |
under $11k
| 0 | 5,901 | 3,753.3652 | 4,265 | 12 |
white
| 17 | 23 | 0.904907 | 0.839966 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 5 | 109 | 28.296875 | 64 | 20 | 37.79688 | 508.6875 | null | null | 0.699951 | 130 | 7.479492 | 245 | 18 | null | 1 | 1 |
no(M2 and SIP pres)
| 1 |
4,575 | 58.33499 | 0 |
male
| 0 | 105 | 939 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 9 |
$11-$25k
| 0 | 298,711 | 201,417.625 | 23,960 | 43.5 |
white
| 31 | 40 | 0.717896 | 0.631958 | 1 | 0 | 0 |
no
| 0.4 | 0.4 |
no dnr
| 105 | 55 | 10.398438 | 110 | 14 | 36.09375 | 170 | null | null | 0.5 | 141 | 7.389648 | 196 | 3 | 2,480 | null | 5 |
SIP>=30
| 5 |
4,576 | 59.34598 | 1 |
male
| 1 | 6 | 6 |
Coma
|
Coma
| 1 | 0 |
$11-$25k
| 94 | 26,989 | 19,152.7812 | 15,365 | 33 |
black
| 18.097656 | 16 | 0.418945 | 0.344971 | 3 | 0 | 0 |
no
| 0.01 | 0 |
dnr after sadm
| 5 | 138 | 7.599609 | 84 | 22 | 36.29688 | null | 4.099609 | 1 | 1 | 140 | null | 83 | 10 | 210 | null | 0 |
<2 mo. follow-up
| 0 |
4,577 | 52.94199 | 0 |
female
| 0 | 14 | 937 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
>$50k
| 0 | 40,230 | 24,462.9844 | 21,977 | 20.666656 |
white
| 17 | 15 | 0.888916 | 0.849976 | 5 | 0 | 0 |
no
| 0.7 | 0.7 |
no dnr
| 14 | 81 | 100 | 104 | 11 | 36.39844 | 159.15625 | null | null | 3.899902 | 135 | 7.319336 | 240 | 98 | 1,356 | 3 | 0 |
no(M2 and SIP pres)
| 0 |
4,578 | 44.00497 | 1 |
male
| 0 | 19 | 441 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 15 |
$11-$25k
| 0 | 42,924 | 30,731.9688 | 28,252 | 28.666656 |
white
| 17.199219 | 11 | 0.914917 | 0.883911 | 2 | 0 | 0 |
no
| 0.8 | 0.8 |
dnr after sadm
| 12 | 62 | 15.699219 | 134 | 30 | 35.89844 | 122.5 | 2.599609 | 18.699219 | 1.799805 | 144 | 7.5 | 168 | 56 | 790 | null | 7 |
Coma or Intub
| 7 |
4,579 | 75.02295 | 1 |
male
| 0 | 8 | 168 |
Lung Cancer
|
Cancer
| 1 | 8 |
under $11k
| 0 | 9,280 | 5,833 | 5,668 | 10 |
white
| 15.398438 | 23 | 0.715942 | 0.437988 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 8 | 65 | 7.5 | 114 | 28 | 38.09375 | 208.5625 | 2.599609 | 1.599854 | 1.799805 | 146 | 7.359375 | 241 | 78 | 2,020 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
4,580 | 60.52798 | 1 |
female
| 1 | 38 | 38 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5 | 12 |
under $11k
| 0 | 334,835 | 253,204 | 217,423 | 21.25 |
white
| 24.699219 | 49 | 0.67395 | 0.578979 | 73 | 1 | 0 |
yes
| 0.2 | 0.1 |
dnr after sadm
| 6 | 75 | 12 | 120 | 24 | 37.09375 | null | 1.5 | 0.899902 | 0.799927 | 136 | null | 75 | 21 | null | null | 0 |
<2 mo. follow-up
| 0 |
4,581 | 66.93799 | 0 |
male
| 0 | 38 | 934 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
$25-$50k
| 0 | 135,947 | 75,008 | 73,737 | 33 |
white
| 36.09375 | 70 | 0.406982 | 0.287964 | 4 | 0 | 0 |
yes
| 0.4 | 0.3 |
no dnr
| 38 | 63 | 10.398438 | 104 | 20 | 37.59375 | 336.625 | null | 0.799927 | 1.699951 | 132 | 7.449219 | 245 | 33 | 880 | null | 2 |
adl>=4 (>=5 if sur)
| 2 |
4,582 | 69.70599 | 0 |
male
| 0 | 11 | 933 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 6 |
$25-$50k
| 0 | 23,536 | 15,357.625 | 10,738 | 24 |
white
| 27.597656 | 52 | 0.718994 | 0.562988 | 2 | 0 | 0 |
no
| null | null |
no dnr
| 11 | 119 | 15.199219 | 66 | 36 | 38.19531 | 303.3125 | null | null | 0.899902 | 133 | 7.509766 | 200 | 7 | 2,280 | 1 | 7 |
no(M2 and SIP pres)
| 7 |
4,583 | 70.43896 | 1 |
male
| 0 | 15 | 613 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 4 | null | 9 | 38,926 | 25,641.9844 | 21,850 | 24.333328 |
white
| 26.199219 | 73 | 0.7229 | 0.637939 | 1 | 0 | 0 |
no
| 0.6 | 0.5 |
no dnr
| 15 | 79 | 0.699951 | 114 | 45 | 36.19531 | 316.625 | null | 3.5 | 8.099609 | 153 | 7.459961 | 186 | 144 | 3,480 | null | null |
no(M2 and SIP pres)
| 2.557617 |
4,584 | 92.15594 | 1 |
male
| 1 | 3 | 3 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 5 | null | 0 | 11,834 | 6,943.1367 | 6,614 | 31 |
white
| 57.5 | 95 | 0.003 | 0 | 2 | 1 | 0 |
no
| null | null |
dnr after sadm
| 1 | 63 | 12 | 120 | 12 | 36.09375 | 263.3125 | 2 | 2.799805 | 0.699951 | 141 | 7.459961 | 140 | 19 | 2,365 | null | 0 |
<2 mo. follow-up
| 0 |
4,585 | 45.59598 | 0 |
female
| 0 | 14 | 933 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 11 |
$11-$25k
| 0 | 31,083 | 20,342.7344 | 18,127 | 8.666664 |
black
| 17.699219 | 32 | 0.903931 | 0.869995 | 3 | 0 | 0 |
no
| 0.85 | 0.8 |
no dnr
| 14 | 96 | 7.299805 | 70 | 20 | 36.29688 | null | 4.099609 | 1 | 1.5 | 136 | null | 139 | 31 | null | 5 | 0 | null | 0 |
4,586 | 21.85899 | 1 |
male
| 1 | 5 | 5 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 0 | 159,990 | 98,132.5 | 61,458 | 69 |
white
| 38.796875 | 72 | 0.635986 | 0.533936 | 48 | 0 | 0 |
no
| null | null |
dnr after sadm
| 4 | 65 | 14.099609 | 106 | 20 | 35.69531 | null | 3.899902 | null | 0.899902 | 128 | null | 97 | 14 | null | null | null |
<2 mo. follow-up
| 2.019531 |
4,587 | 49.69199 | 1 |
female
| 1 | 110 | 110 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 9 |
under $11k
| 0 | 536,290 | null | null | 34.25 |
black
| 36.296875 | 66 | 0.590942 | 0.481995 | 5 | 1 | 0 |
no
| 0.3 | 0.2 |
dnr after sadm
| 69 | 78 | 19.097656 | 64 | 9 | 36.59375 | 380 | 2.299805 | 1.599854 | 5 | 129 | 7.379883 | 230 | 99 | 1,290 | null | 1 |
adl>=4 (>=5 if sur)
| 1 |
4,588 | 70.83099 | 1 |
male
| 0 | 25 | 270 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 4 |
under $11k
| 0 | 39,684 | 25,477.6406 | 31,305 | 12.5 |
other
| 24.398438 | 33 | 0.779907 | 0.708984 | 1 | 1 | 0 |
no
| 0.8 | 0.75 |
no dnr
| 25 | 61 | 17.699219 | 106 | 40 | 38.59375 | 177.5 | 2.099609 | 0.899902 | 3.299805 | 151 | 7.469727 | 190 | 149 | 173 | null | 6 |
adl>=4 (>=5 if sur)
| 6 |
4,589 | 62.54599 | 1 |
male
| 0 | 13 | 189 |
MOSF w/Malig
|
ARF/MOSF
| 4 | 14 |
$25-$50k
| 0 | 40,684 | 25,259.9219 | 27,094 | 32.5 |
white
| 31.5 | 47 | 0.520996 | 0.404968 | 1 | 0 | 0 |
yes
| 0.7 | 0.5 |
no dnr
| 13 | 73 | 8.398438 | 70 | 28 | 36.19531 | 191.40625 | null | null | 0.5 | 139 | 7.389648 | 80 | 16 | 1,100 | 1 | 6 |
adl>=4 (>=5 if sur)
| 6 |
4,590 | 79.95294 | 1 |
male
| 1 | 26 | 26 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null |
under $11k
| 41 | 101,923 | 70,486.75 | 59,330 | 34.5 |
black
| 17.5 | 36 | 0.736938 | 0.655884 | 1 | 0 | 0 |
no
| 0.6 | 0.5 |
dnr after sadm
| 23 | 119 | 37.296875 | 176 | 28 | 36 | 223.3125 | 2.299805 | 0.299988 | 0.699951 | 142 | 7.5 | 148 | 47 | 1,910 | null | null |
<2 mo. follow-up
| 2.765137 |
4,591 | 60.20499 | 1 |
male
| 0 | 12 | 193 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 7 |
under $11k
| 0 | 36,077 | 22,552.1875 | 21,125 | 34 |
white
| 27.699219 | 55 | 0.768921 | 0.694946 | 1 | 1 | 0 |
no
| 0.4 | 0.25 |
no dnr
| 12 | 113 | 28.097656 | 106 | 44 | 39 | 240 | null | 4.5 | 0.699951 | 137 | 7.419922 | 117 | 8 | 4,900 | null | 1 |
no(M2 and SIP pres)
| 1 |
4,592 | 58.09998 | 1 |
male
| 0 | 13 | 108 |
Lung Cancer
|
Cancer
| 2 | null | null | 0 | 12,119 | 7,854.8711 | 7,984 | 7.5 |
white
| 14.199219 | 13 | 0.773926 | 0.529907 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.4 |
no dnr
| 13 | 27 | 15.599609 | 135 | 12 | 37.89844 | 218 | 1.799805 | null | 2.399902 | 135 | 7.289062 | 43 | 48 | 140 | null | null | null | 2.822266 |
4,593 | 82.37396 | 1 |
female
| 0 | 20 | 826 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 7 |
$11-$25k
| 0 | 52,865 | 36,617.4062 | 33,561 | 25.666656 |
black
| 30 | 44 | 0.573975 | 0.463989 | 3 | 1 | 0 |
no
| 0.5 | 0.4 |
no dnr
| 20 | 53 | 17 | 70 | 34 | 38.79688 | 122 | null | 0.699951 | 1.599854 | 151 | 7.479492 | 185 | 28 | 2,080 | null | 0 |
no(M2 and SIP pres)
| 0 |
4,594 | 70.18799 | 0 |
female
| 0 | 15 | 926 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 8 | null | 9 | 46,529 | 31,239.9219 | 25,634 | 27 |
black
| 17.597656 | 23 | 0.851929 | 0.80188 | 1 | 0 | 0 |
no
| 0.25 | 0.2 |
no dnr
| 15 | 76 | 4 | 120 | 28 | 38.09375 | null | 2.199707 | 0.599976 | 1.899902 | 131 | null | 103 | 48 | 1,150 | null | 0 |
no(M2 and SIP pres)
| 0 |
4,595 | 66.44995 | 1 |
female
| 0 | 19 | 69 |
Coma
|
Coma
| 3 | null | null | 55 | 28,300 | 19,586.7188 | 21,057 | 13.666664 |
black
| 24.199219 | 52 | 0.415955 | 0.342957 | 1 | 1 | 0 |
no
| 0.8 | 0.7 |
dnr after sadm
| 1 | 145 | 26 | 144 | 35 | 39 | 84.60938 | null | 0.399963 | 0.899902 | 139 | 7.439453 | 94 | 19 | 2,595 | null | 7 | null | 7 |
4,596 | 72.43298 | 0 |
female
| 0 | 42 | 926 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 8 |
under $11k
| 0 | 48,857 | 32,073.5781 | 38,315 | 14.25 |
white
| 22.199219 | 28 | 0.807983 | 0.743896 | 1 | 0 | 0 |
no
| 0.7 | 0.5 |
no dnr
| 42 | 71 | 7 | 64 | 22 | 36.59375 | 291.25 | null | null | 1.199951 | 141 | 7.399414 | 197 | 20 | 1,220 | 0 | null |
no(M2 and SIP pres)
| 0.494751 |
4,597 | 40.70398 | 1 |
male
| 0 | 71 | 99 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 12 |
under $11k
| 0 | 207,743 | 131,070.938 | 31,629 | 25.75 |
black
| 32 | 32 | 0.793945 | 0.668945 | 1 | 0 | 0 |
no
| null | null |
dnr after sadm
| 39 | 79 | 7.599609 | 116 | 24 | 37.79688 | null | null | 0.399963 | 1 | 141 | null | 103 | 14 | 1,925 | 2 | 6 |
adl>=4 (>=5 if sur)
| 6 |
4,598 | 83.76495 | 1 |
male
| 0 | 4 | 99 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 9 |
$11-$25k
| 0 | 5,175 | 3,558.0781 | 2,754 | 17 |
white
| 18.796875 | 29 | 0.814941 | 0.699951 | 1 | 1 | 0 |
no
| 0.5 | 0.25 |
no dnr
| 4 | 124 | 12.298828 | 136 | 26 | 38.39844 | 142 | 4.599609 | 0.199982 | 1.299805 | 144 | 7.419922 | 474 | 20 | 2,155 | 3 | 3 |
adl>=4 (>=5 if sur)
| 3 |
4,599 | 37.80399 | 1 |
male
| 0 | 5 | 182 |
Lung Cancer
|
Cancer
| 1 | null | null | 0 | 5,296 | 3,480.457 | 3,060 | 2 |
white
| 10.5 | 14 | 0.85498 | 0.677979 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.5 |
no dnr
| 5 | 122 | 9.599609 | 140 | 28 | 36.89844 | null | null | null | 1 | 140 | null | 148 | 5 | null | null | null | null | 1.781982 |
4,600 | 73.57996 | 1 |
male
| 1 | 7 | 7 |
MOSF w/Malig
|
ARF/MOSF
| 2 | 14 |
$11-$25k
| 0 | 51,620 | 33,419.8125 | 31,452 | 29.5 |
white
| 33.09375 | 60 | 0.343994 | 0.227997 | 12 | 1 | 0 |
yes
| 0.9 | 0.8 |
dnr after sadm
| 7 | 0 | 1.199951 | 0 | 0 | 38.89844 | 93.32812 | null | 1.799805 | 3.799805 | 136 | 7.259766 | 91 | 88 | 1,510 | null | null |
<2 mo. follow-up
| 2.959473 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.